However, in immunocompetent patients, this condition may be transient, with the return of CD8+ T-cells boosted by effector CD4+ and memory CD4+ T-cells within 2 to 3 months, as observed in SARS-CoV infections (59). The gene discussed is CD4; the disease is severe acute respiratory syndrome.